Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPNE2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CPNE2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPNE2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CPNE2 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CPNE2 mRNA | CTD | PMID:32277265 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPNE2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cpne2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPNE2 mRNA | CTD | PMID:21570461 and PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPNE2 mRNA | CTD | PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPNE2 mRNA | CTD | PMID:17942748 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-palmitoylglycerol | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of CPNE2 mRNA | CTD | PMID:37199045 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CPNE2 mRNA | CTD | PMID:30951980 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CPNE2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CPNE2 gene | CTD | PMID:27153756 | aflatoxin B1 | affects methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of CPNE2 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CPNE2 mRNA | CTD | PMID:21934132 and PMID:33167477 | belinostat | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of CPNE2 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CPNE2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CPNE2 3' UTR and Benzo(a)pyrene results in decreased methylation of CPNE2 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of CPNE2 intron | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CPNE2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CPNE2 mRNA | CTD | PMID:32156529 | bisphenol A | decreases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CPNE2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CPNE2 mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CPNE2 gene | CTD | PMID:28505145 | cadmium atom | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPNE2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPNE2 mRNA | CTD | PMID:35301059 | carbon nanotube | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of CPNE2 mRNA | CTD | PMID:25620056 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of CPNE2 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CPNE2 mRNA | CTD | PMID:20106945 and PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of CPNE2 mRNA | CTD | PMID:23640034 | diazinon | increases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of CPNE2 gene | CTD | PMID:22964155 | dioxygen | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPNE2 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPNE2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CPNE2 mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | entinostat results in increased expression of CPNE2 mRNA | CTD | PMID:27188386 | fenthion | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of CPNE2 mRNA | CTD | PMID:34813904 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CPNE2 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CPNE2 protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CPNE2 mRNA | CTD | PMID:35811015 | methapyrilene | increases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of CPNE2 intron | CTD | PMID:30157460 | methidathion | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | methidathion results in decreased expression of CPNE2 mRNA | CTD | PMID:34813904 | monosodium L-glutamate | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of CPNE2 mRNA | CTD | PMID:22078008 | N-methyl-4-phenylpyridinium | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CPNE2 mRNA | CTD | PMID:24810058 | O-methyleugenol | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of CPNE2 mRNA | CTD | PMID:32234424 | ozone | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CPNE2 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CPNE2 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CPNE2 mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPNE2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CPNE2 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of CPNE2 mRNA | CTD | PMID:36326898 | pirinixic acid | decreases expression | ISO | Cpne2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CPNE2 mRNA | CTD | PMID:17426115 | pirinixic acid | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CPNE2 mRNA | CTD | PMID:18301758 | potassium chromate | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CPNE2 mRNA | CTD | PMID:22714537 | quercetin | increases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of CPNE2 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CPNE2 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPNE2 mRNA | CTD | PMID:27188386 | sodium arsenite | affects expression | ISO | CPNE2 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of CPNE2 mRNA | CTD | PMID:34032870 | sodium arsenite | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CPNE2 protein | CTD | PMID:30528433 | succimer | multiple interactions | ISO | Cpne2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPNE2 mRNA | CTD | PMID:21641980 | sunitinib | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CPNE2 mRNA | CTD | PMID:31533062 | tamoxifen | increases expression | ISO | Cpne2 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of CPNE2 mRNA | CTD | PMID:25123088 | trichostatin A | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CPNE2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | CPNE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPNE2 mRNA | CTD | PMID:27188386 | valproic acid | increases methylation | ISO | CPNE2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CPNE2 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CPNE2 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | CPNE2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CPNE2 mRNA | CTD | PMID:25979313 | |